Tenet Healthcare shares drop 30%, now trading at attractive 10x earnings with strong 2025 outlook.

Tenet Healthcare's stock has fallen 30% from recent highs, now trading at a compelling valuation of 10 times adjusted earnings. The company reported 2025 adjusted earnings of $17 per share, surpassing previous guidance, and expects stable earnings and strong buybacks in 2026. Revenue growth is driven by higher pricing despite flat volumes and margin pressure, maintaining overall business stability. Despite challenges in the sector, Tenet's low debt and attractive earnings yield make it a promising investment opportunity.